Medication adherence in schizophrenia: patient perspectives and the clinical utility of paliperidone ER
Michael Birnbaum1, Zafar Sharif21St. Luke’s-Roosevelt Hospital Center, 1111 Amsterdam Ave, New York, NY, USA; 2Columbia University College of Physicians and Surgeons, New York, NY, USAAbstract: Antipsychotic medications provide the foundation for treatment of acute exacerbations as wel...
Main Authors: | Michael Birnbaum, Zafar Sharif |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2008-12-01
|
Series: | Patient Preference and Adherence |
Online Access: | http://www.dovepress.com/medication-adherence-in-schizophrenia-patient-perspectives-and-the-cli-a2751 |
Similar Items
-
Manic Symptoms during a Switch from Paliperidone ER to Paliperidone Palmitate in a Patient with Schizophrenia
by: Kadir Demirci, et al.
Published: (2015-01-01) -
Paliperidone ER and oral risperidone in patients with schizophrenia: a comparative database analysis
by: Schooler Nina, et al.
Published: (2011-02-01) -
A cost-utility analysis of Amisulpride and Paliperidone in the treatment of Schizophrenia
by: Ali Abdall-Razak, et al.
Published: (2019-09-01) -
Paliperidone ER: a review of the clinical trial data
by: Philip G Janicak, et al.
Published: (2007-01-01) -
Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia
by: Mathews M, et al.
Published: (2019-05-01)